PharmaCyte (NASDAQ: PMCB) takes a reverse stock split to regain Nasdaq compliance
What happened PharmaCyte Biotech, Inc. (NASDAQ: PMCB) put a 1-for-19 reverse split of its common stock into effect on Nov. 12. The company says the split should lift the share price so it can regain compliance with the minimum bid price rule for The Nasdaq Capital Market. Shares outstanding fall from approximately 10,755,649 as of […]
17 Nov 02:15 · The Markets Daily